Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Clin Infect Dis ; 77(4): 645-648, 2023 08 22.
Artículo en Inglés | MEDLINE | ID: mdl-37073575

RESUMEN

The timing of maternal pertussis vaccination influences the titers of cord-blood anti-pertussis antibodies. Whether it affects their avidity is unknown. We demonstrate in 298 term and 72 preterm neonates that antibody avidity is independent of the timing of maternal vaccination, whether comparing second with third trimester or intervals before birth.


Asunto(s)
Anticuerpos Antibacterianos , Tos Ferina , Recién Nacido , Embarazo , Femenino , Humanos , Inmunidad Materno-Adquirida , Vacunación , Tos Ferina/prevención & control , Tercer Trimestre del Embarazo
2.
Clin Infect Dis ; 64(8): 1129-1132, 2017 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-28329335

RESUMEN

Preterm infants are most vulnerable to pertussis. Whether they might benefit from maternal immunization is unknown. Extending our previous results in term neonates, this observational study demonstrates that second- rather than third-trimester maternal vaccination results in higher birth anti-pertussis toxin titers in preterm neonates.


Asunto(s)
Anticuerpos Antibacterianos/sangre , Inmunidad Materno-Adquirida , Esquemas de Inmunización , Recien Nacido Prematuro , Vacuna contra la Tos Ferina/administración & dosificación , Vacuna contra la Tos Ferina/inmunología , Tos Ferina/prevención & control , Adolescente , Adulto , Femenino , Humanos , Recién Nacido , Embarazo , Segundo Trimestre del Embarazo , Tercer Trimestre del Embarazo , Estudios Prospectivos , Adulto Joven
3.
Clin Infect Dis ; 62(7): 829-836, 2016 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-26797213

RESUMEN

BACKGROUND: Maternal immunization against pertussis is currently recommended after the 26th gestational week (GW). Data on the optimal timing of maternal immunization are inconsistent. METHODS: We conducted a prospective observational noninferiority study comparing the influence of second-trimester (GW 13-25) vs third-trimester (≥GW 26) tetanus-diphtheria-acellular pertussis (Tdap) immunization in pregnant women who delivered at term. Geometric mean concentrations (GMCs) of cord blood antibodies to recombinant pertussis toxin (PT) and filamentous hemagglutinin (FHA) were assessed by enzyme-linked immunosorbent assay. The primary endpoint were GMCs and expected infant seropositivity rates, defined by birth anti-PT >30 enzyme-linked immunosorbent assay units (EU)/mL to confer seropositivity until 3 months of age. RESULTS: We included 335 women (mean age, 31.0 ± 5.1 years; mean gestational age, 39.3 ± 1.3 GW) previously immunized with Tdap in the second (n = 122) or third (n = 213) trimester. Anti-PT and anti-FHA GMCs were higher following second- vs third-trimester immunization (PT: 57.1 EU/mL [95% confidence interval {CI}, 47.8-68.2] vs 31.1 EU/mL [95% CI, 25.7-37.7], P < .001; FHA: 284.4 EU/mL [95% CI, 241.3-335.2] vs 140.2 EU/mL [95% CI, 115.3-170.3], P < .001). The adjusted GMC ratios after second- vs third-trimester immunization differed significantly (PT: 1.9 [95% CI, 1.4-2.5]; FHA: 2.2 [95% CI, 1.7-3.0], P < .001). Expected infant seropositivity rates reached 80% vs 55% following second- vs third-trimester immunization (adjusted odds ratio, 3.7 [95% CI, 2.1-6.5], P < .001). CONCLUSIONS: Early second-trimester maternal Tdap immunization significantly increased neonatal antibodies. Recommending immunization from the second trimester onward would widen the immunization opportunity window and could improve seroprotection.


Asunto(s)
Anticuerpos Antibacterianos/inmunología , Bordetella pertussis/inmunología , Inmunidad Materno-Adquirida/inmunología , Inmunización/estadística & datos numéricos , Vacuna contra la Tos Ferina/administración & dosificación , Tos Ferina/inmunología , Tos Ferina/prevención & control , Adulto , Anticuerpos Antibacterianos/sangre , Femenino , Humanos , Recién Nacido , Enfermedades del Recién Nacido/prevención & control , Vacuna contra la Tos Ferina/uso terapéutico , Embarazo , Complicaciones Infecciosas del Embarazo/prevención & control , Estudios Prospectivos , Factores de Tiempo
4.
PLoS One ; 17(7): e0271065, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35830435

RESUMEN

BACKGROUND: Recent studies have shown that elective induction of labor versus expectant management after 39 weeks of pregnancy result in lower incidence of perinatal complications, while the proportion of cesarean deliveries remains stable, or even decreases. Still, evidence regarding collateral consequences of the potential increase of induction of labor procedures is still lacking. Also, the results of these studies must be carefully interpreted and thoroughly counter-balanced with women's thoughts and opinions regarding the active management of the last weeks of pregnancy. Therefore, it may be useful to develop a tool that aids in the decision-making process by differentiating women who will spontaneously go into labor from those who will require induction. OBJECTIVE: To develop a predictive model to calculate the probability of spontaneous onset of labor at term. METHODS: We designed a prospective national multicentric observational study including women enrolled at 39 weeks of gestation, carrying singleton pregnancies. After signing an informed consent form, several clinical, ultrasonographic, biophysical and biochemical variables will be collected by trained staff. If delivery has not occurred at 40 weeks of pregnancy, a second visit and evaluation will be performed. Prenatal care will be continued according to current hospital guidelines. Once recruitment is completed, the information gathered will be used to develop a logistic regression-based predictive model of spontaneous onset of labor between 39 and 41 weeks of gestation. A secondary exploration of the data collected at 40 weeks, as well as a survival analysis regarding time-to-delivery outcomes will also be performed. A total sample of 429 participants is needed for the expected number of events. CONCLUSION: This study aims to develop a model which may help in the decision-making process during follow-up of the last weeks of pregnancy. TRIAL REGISTRATION: NCT05109247 (clinicaltrials.gov).


Asunto(s)
Trabajo de Parto Inducido , Trabajo de Parto , Cesárea , Femenino , Edad Gestacional , Humanos , Trabajo de Parto Inducido/métodos , Estudios Observacionales como Asunto , Embarazo , Estudios Prospectivos
5.
Am J Ophthalmol ; 184: 129-136, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-29032108

RESUMEN

PURPOSE: To identify biomechanical and topographic changes of the cornea during pregnancy and the postpartum period and its association to hormonal changes. DESIGN: Prospective single-center observational cohort study. METHODS: Participants were 24 pregnant women (48 eyes), monitored throughout pregnancy and after delivery. Biomechanical and topographic corneal properties were measured using the Ocular Response Analyzer (ORA) and a Scheimpflug imaging system (Pentacam HR) each trimester and 1 month after delivery. At the same consultations blood plasma levels of estradiol (E2) and thyroid hormones (TSH, T3t, T4t) were also determined. A factorial MANCOVA was used to detect interactions between hormonal plasma levels and ocular parameters. RESULTS: Significant differences in corneal biomechanical and topographic parameters were found during pregnancy in relation to T3t (p = .01), T4t (p < .001), T3t/T4t (P = .001), and TSH (p = .001) plasma levels. E2 plasma levels (p = .092) and time period of measurement (p = .975) did not significantly affect corneal parameters. TSH levels significantly affected the maximal keratometry reading (p = .036), the vertical keratometry reading (p = .04), and the index of height asymmetry (p = .014). Those results persist after excluding hypothyroidism patients from the statistical analysis. CONCLUSIONS: Hormonal changes affecting corneal biomechanics and topography during pregnancy could be thyroid related. Dysthyroidism may directly influence corneal biomechanics and represents a clinically relevant factor that needs further investigation.


Asunto(s)
Córnea/fisiopatología , Enfermedades de la Córnea/diagnóstico , Topografía de la Córnea/métodos , Complicaciones del Embarazo , Hormonas Tiroideas/sangre , Adulto , Córnea/patología , Enfermedades de la Córnea/sangre , Enfermedades de la Córnea/fisiopatología , Elasticidad , Femenino , Estudios de Seguimiento , Humanos , Periodo Posparto/sangre , Embarazo , Estudios Prospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA